Effect of apolipoprotein E on cell viability in a human neuroblastoma cell line: Influence of oxidation and lipid-association

Neuroscience Letters

Volumn 285, Issue 3, 2000, Pages 173-176

  Hoy, Aline ^a   Leininger Muller, Brigitte ^a   Jolivalt, Corinne ^a   Siest, Gerard ^a  

^a Centre du Medicament URA CNRS 597   (France)

Author keywords

Apolipoprotein E; Lipoprotein; Myeloperoxidase; Neuroblastoma cells; Oxidation; Toxicity

Indexed keywords

AMYLOID PRECURSOR PROTEIN; LIPOPROTEIN; MYELOPEROXIDASE; PHOSPHOLIPID; PROTEOHEPARAN SULFATE;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROTOXICITY; OXIDATION; PRIORITY JOURNAL;

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CELL SURVIVAL; HUMANS; NEUROBLASTOMA; OXIDATION-REDUCTION; PHOSPHOLIPIDS; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED;

EID: 0034685852     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01059-4     Document Type: Article

References (25)

1. Bassett C.N., Neely M.D., Sidell K.R., Markesbery W.R., Swift L.L., Montine T.J. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34:(12):1999;1273-1280.
2. Carlsson J., Armstrong V.W., Reiber H., Felgenhauer K., Seidel D. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta. 196:1991;167-176.
3. Davies K.J.A., Delsignore M.E. Protein damage and degradation by oxygen radicals. J. Biol. Chem. 262:1987;9908-9913.
4. Hu J., Ladu M.J., Van Eldik L.J. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. J. Neurochem. 71:(4):1998;1626-1634.
5. Ji Z.S., Pitas R.E., Mahley R.W. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 273:(22):1998;13452-13460.
6. Jolivalt C., Leininger-Muller B., Drozdz R., Naskalsky J.W., Siest G. Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neurosci. Lett. 210:1996;61-64.
7. Jolivalt C., Leininger-Muller B., Bertrand P., Herber R., Christen Y., Siest G. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Rad. Biol. Med. 28:(1):2000;129-140.
8. Jordan J., Galindo M.F., Miller R.J., Reardon C.A., Getz G.S., Ladu M.J. Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18:(1):1998;195-204.
9. Kisilevsky R. Inflammation-associated amyloidogenesis. Lessons for Alzheimer's amyloidogenesis. Mol. Neurobiol. 8:(1):1994;65-66.
10. LaDu M.J., Gilligan S.M., Lukens J.R., Cabana V.G., Reardon C.A., Van Eldik L.J., Holtzman D.M. Nascent astrocytes particles differ from lipoproteins in CSF. J. Neurochem. 70:1998;2070-2081.
11. LaFerla F.M., Troncoso J.C., Strickland D.K., Kawas C.H., Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization. J. Clin. Invest. 100:(2):1997;310-320.
12. Leininger-Muller B., Jolivalt C., Bertrand P., Siest G. Oxidation of human apolipoprotein E and cerebral enzymatic systems. Alz. Rep. 1:1998;95-99.
13. Leininger-Muller B., Jolivalt C., Bertrand P., Siest G. Oxidation of human apolipoprotein E: isoform susceptibility and protection with Ginkgo biloba extract (EGb 761). Packer L., Christen Y. Advances in Ginkgo biloba Extract Research, Vol. 7, Ginkgo biloba Extract (EGb 761): Lessons From Cell Biology. 1998;57-68 Elsevier, Paris.
14. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, J. Neurochem. 69:(2):1997;581-593.
15. Lucotte G., Visvikis S., Leininger-Muller B., David F., Berriche S., Reveilleau S., Coderc R., Babion M.C., Siest G. Association of apoE allele ε4 with late-onset sporadic Alzheimer's disease. Am. J. Med. Gen. 54:(3):1994;286-288.
16. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
17. Marques M.A., Tolar M., Crutcher K.A. Apolipoprotein E exhibits isoform-specific neurotoxicity. Alz. Res. 3:1997;1-6.
18. Merched A., Blain H., Visvikis S., Herbeth B., Jeandel C., Siest G. Cerebrospinal fluid apolipoprotein E level is increased in late onset Alzheimer's disease. J. Neurol. Sci. 145:1997;33-39.
19. Miyata M., Smith J.D. Apolipoprotein E allele specific antioxidant activity and effects on cytotoxicity by oxidative insults and β amyloid peptide. Nat. Genet. 14:1996;55-61.
20. Namba Y., Tomonoga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeld-Jakob disease. Brain Res. 541:1991;163-166.
21. Neill D., Hughes D., Edwardson J.A., Rima B.K., Allsop D. Human IMR32 neuroblastoma cells as a model cell line in Alzheimer's disease research. J. Neurosci. Res. 39:1994;482-493.
22. Pirttila T., Soininen H., Heinonen O., Lehtimaki T., Bogdanovic N., Paljarvi L., Kosunen O., Winblad B., Riekkinen P. Sr, Wisniewski H.M., Mehta P.D. Apolipoprotein E levels in brains from Alzheimer's disease patients and controls. Brain Res. 722:(1/2):1996;71-77.
23. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155:1999;31-41.
24. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak-Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
25. Whitson J.S., Mims M.P., Strittmatter W.J., Yamaki T., Morrisett J.D., Appel S.H. Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Comm. 199:(1):1994;163-170.